本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Trevi Therapeutics Inc.

6.84
+0.13001.94%
盘后6.55-0.2885-4.22%19:19 EDT
成交量:157.60万
成交额:1,075.08万
市值:8.15亿
市盈率:-15.38
高:7.03
开:6.71
低:6.69
收:6.71
数据加载中...
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/23

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/21

重要事件披露

Form 8-K - Current report
2024/10/04

重要事件披露

Form 8-K - Current report
2024/10/01

重要事件披露

Form 8-K - Current report
2024/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/11

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/13

重要事件披露

Form 8-K - Current report
2024/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/25

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]